Top Page
Challenger
(Sydney:CGF)
Challenger (CGF) vs. iShares MSCI Australia ETF (EWA)
Challenger Business Overview & Revenue Model
Challenger Financial Statement Overview
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.74B | 750.50M | 3.28B | 2.23B | -414.30M | 3.03B |
| Gross Profit | 295.10M | 750.50M | 635.90M | 652.20M | 1.36B | 1.79B |
| EBITDA | 1.23B | 1.11B | 924.70M | 970.50M | 414.30M | 1.17B |
| Net Income | 458.80M | 192.30M | 129.90M | 287.50M | 253.70M | 592.30M |
Balance Sheet | ||||||
| Total Assets | 35.37B | 34.95B | 33.41B | 30.98B | 29.74B | 29.99B |
| Cash, Cash Equivalents and Short-Term Investments | 755.20M | 32.39B | 573.20M | 593.40M | 733.10M | 989.40M |
| Total Debt | 8.07B | 8.27B | 7.13B | 5.89B | 5.85B | 6.39B |
| Total Liabilities | 31.26B | 31.09B | 29.52B | 26.81B | 25.75B | 26.17B |
| Stockholders Equity | 4.11B | 3.86B | 3.88B | 4.16B | 3.99B | 3.83B |
Cash Flow | ||||||
| Free Cash Flow | 1.88B | 399.40M | 841.80M | 1.27B | 2.48B | 2.56B |
| Operating Cash Flow | 1.88B | 399.60M | 843.70M | 1.27B | 2.49B | 2.58B |
| Investing Cash Flow | -1.95B | -1.18B | -1.94B | -1.34B | -2.12B | -865.00M |
| Financing Cash Flow | 265.40M | 854.70M | 1.08B | -35.00M | -619.80M | -1.38B |
Challenger Technical Analysis
Challenger Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | AU$6.33B | 111.22 | 67.81% | 1.45% | 28.29% | 39.39% | |
62 Neutral | AU$124.54M | 24.01 | 8.88% | ― | 21.79% | -23.00% | |
61 Neutral | AU$3.40B | 27.20 | 19.56% | 3.45% | 37.42% | 38.37% | |
60 Neutral | $6.15B | 12.55 | 4.84% | 3.10% | 11.78% | 47.53% | |
56 Neutral | AU$1.93B | 18.31 | 5.31% | ― | 16.78% | 22.86% | |
50 Neutral | AU$2.13B | -125.19 | -3.34% | 6.01% | 2.87% | 87.93% |
Challenger Corporate Events
Challenger Limited has declared a discretionary quarterly distribution of AUD 1.30 per Challenger Capital Notes 4 security (ASX: CGFPD), linked to 3‑month BBSW plus a 3.60% margin. The distribution relates to the quarter ending 24 May 2026, with an ex-date of 14 May, a record date of 15 May, and payment scheduled for 25 May 2026, subject to no payment conditions being in effect.
The announcement underscores Challenger’s ongoing use of hybrid capital notes to manage its funding structure and provide income to noteholders within regulatory and prospectus constraints. As the distributions on these perpetual, non-cumulative notes remain discretionary and contingent on specified conditions, investors are reminded that payments are not guaranteed and depend on Challenger’s compliance with capital and payment restrictions.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$9.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has notified the market that it has ceased to be a substantial holder in HUB24 Limited, formally lodging a notice with the ASX to confirm the change in its relevant interest. The move indicates that Challenger and its associated entities have reduced their shareholding below the substantial holder threshold, potentially altering its strategic exposure to HUB24 and slightly reshaping the ownership profile of the wealth platform provider.
The notice, signed by company secretary Linda Matthews, consolidates the position of Challenger and its related entities under the disclosure rules of the Corporations Act. While financial terms and transaction details are not disclosed, the change underscores ongoing portfolio adjustments within Challenger’s investment holdings and may be of interest to investors tracking cross-shareholdings and governance influence in the Australian wealth management sector.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$8.70 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has confirmed it is in advanced but incomplete talks to partner with Pepper Group ANZ HoldCo to jointly acquire Pepper Money Limited via a scheme of arrangement. Under the proposal, Pepper Group would initially hold at least the same economic interest it currently has in Pepper Money, while Challenger would own no more than 25% of the lender’s shares.
The potential investment would give Challenger long-term strategic access to fixed income assets to support growth and returns, aligning with its retirement-focused investment model. The company stressed it will remain a disciplined allocator of capital, does not intend to raise common equity to fund any deal, and expects any transaction to be strategic and earnings-per-share accretive, while cautioning there is no certainty an agreement will be reached.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$9.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has notified the ASX that it and its associated entities have ceased to be a substantial shareholder in Smartgroup Corporation Limited, lodging the required Form 605 notice of ceasing to be a substantial holder. The change reduces Challenger’s significant voting interest exposure to Smartgroup, signalling an adjustment in its investment portfolio that may slightly reshape its listed equity holdings but does not indicate any disclosed change to its core retirement and investment services operations.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$9.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has notified the ASX that it has ceased to be a substantial holder in Telix Pharmaceuticals Ltd, formally lodging the required notice under the Corporations Act. The change indicates Challenger and its associated entities have reduced their holding in Telix below the substantial shareholder threshold, signaling a shift in their investment exposure to the biotech company and potentially altering Telix’s institutional shareholder base and governance dynamics.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$9.50 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has issued 179,017 unquoted performance rights under its employee incentive scheme, effective 16 January 2026. The grant of these performance rights, which will not be quoted on the ASX, underscores the company’s continued use of equity-based remuneration to align staff incentives with shareholder interests and support the retention and motivation of key employees.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$9.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has notified the market that 73,857 performance rights (ASX code: CGFAA) have lapsed as of 31 December 2025 after the conditions attached to those rights were not met or became incapable of being satisfied. The cessation of these securities reflects an adjustment to Challenger’s issued capital under its performance-based incentive arrangements, with no new shares issued as a result, and signals that certain performance hurdles tied to these rights were not achieved over the relevant period.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$10.25 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has disclosed that it, together with its controlled entities, holds or has derivative exposure to 50,197 ordinary shares in Challenger, representing 0.0073% of the company’s total issued capital, primarily via the Challenger Performance Plan Trust administered by CPU Share Plans Pty Limited. The notice, lodged under a Corporations Act exemption, details small net changes in this interest since October 2025 due to the forfeiture of shares and interests back to the trust from employee share plans, underscoring that current levels of treasury-like holdings tied to staff incentives remain immaterial in the context of Challenger’s overall share base but are being closely tracked for regulatory and governance transparency.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$10.25 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced its financial calendar for 2026, detailing key dates for half-year and full-year results, dividend announcements, and other significant events. This schedule provides stakeholders with a clear timeline for financial disclosures, which is crucial for investors and market analysts in planning and decision-making.
The most recent analyst rating on (AU:CGF) stock is a Buy with a A$10.25 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.